Six firms have contacted Boots about the sale of its medicines division.

Pharmaceutical companies GlaxoSmithKline, Johnson & Johnson, Bayer, Novartis, Procter & Gamble and Reckitt Benckiser are all interested in purchasing the business which includes the brands Nurofen, Strepsils and Clearasil.

Analysts expect the business to sell for £1bn-£1.2bn when Boots puts the division up for sale next month.